Barbara Pascucci

Dr. Barbara Pascucci

Institute of Crystallography, Consiglio Nazionale delle Ricerche
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 1998 in Biochemistry
Verified
Journal Article
Closed access
PFPaola Fortini
Paola Fortini
Barbara PascucciBarbara Pascucci
Barbara Pascucci
EPEleonora Parlanti
Eleonora Parlanti
RSRobert W. Sobol
Robert W. Sobol
SWSamuel H. Wilson
Samuel H. Wilson
EDEugenia Dogliotti
Eugenia Dogliotti

1 November 1999 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
Barbara PascucciBarbara Pascucci
Barbara Pascucci
MSManuel Stucki
Manuel Stucki
ZJZophonı́as O. Jónsson
Zophonı́as O. Jónsson
EDEugenia Dogliotti
Eugenia Dogliotti
UHUlrich Hübscher
Ulrich Hübscher
Among the different base excision repair pathways known, the long patch base excision repair of apurinic/apyrimidinic sites is an important mechanism that requires proliferating cell nuclear antigen. We have reconstituted this pathway using purified human proteins. Our data indicated that efficient repair is dependent on six components including AP endonuclease, replication factor C, proliferating cell nuclear antigen, DNA polymerases δ or ε, flap endonuclease 1, and DNA ligase I. Fine mapping of the nucleotide replacement events showed that repair patches extended up to a maximum of 10 nucleotides 3′ to the lesion. However, almost 70% of the repair synthesis was confined to 2–4-nucleotide patches and DNA ligase I appeared to be responsible for limiting the repair patch length. Moreover, both proliferating cell nuclear antigen and flap endonuclease 1 are required for the production and ligation of long patch repair intermediates suggesting an important role of this complex in both excision and resynthesis steps.

18 August 1998 in Oncogene
Verified
Journal Article
Closed access
MSM Stucki
M Stucki
Barbara PascucciBarbara Pascucci
Barbara Pascucci
EPE Parlanti
E Parlanti
PFPaola Fortini
Paola Fortini
SWS H Wilson
S H Wilson
EDE Dogliotti
E Dogliotti

1 October 2003 in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Verified
Journal Article
Closed access
PFPaola Fortini
Paola Fortini
Barbara PascucciBarbara Pascucci
Barbara Pascucci
EPE. Parlanti
E. Parlanti
MDM. D’eRrico
M. D’eRrico
VSValeria Simonelli
Valeria Simonelli
EDE. Dogliotti
E. Dogliotti

31 March 2016 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
PFPaola Fortini
Paola Fortini
CFC Ferretti
C Ferretti
Egidio IorioEgidio Iorio
Egidio Iorio
MCM Cagnin
M Cagnin
LGL Garribba
L Garribba
EDEugenia Dogliotti
Eugenia Dogliotti
Although the mechanisms controlling skeletal muscle homeostasis have been identified, there is a lack of knowledge of the integrated dynamic processes occurring during myogenesis and their regulation. Here, metabolism, autophagy and differentiation were concomitantly analyzed in mouse muscle satellite cell (MSC)-derived myoblasts and their cross-talk addressed by drug and genetic manipulation. We show that increased mitochondrial biogenesis and activation of mammalian target of rapamycin complex 1 inactivation-independent basal autophagy characterize the conversion of myoblasts into myotubes. Notably, inhibition of autophagic flux halts cell fusion in the latest stages of differentiation and, conversely, when the fusion step of myocytes is impaired the biogenesis of autophagosomes is also impaired. By using myoblasts derived from p53 null mice, we show that in the absence of p53 glycolysis prevails and mitochondrial biogenesis is strongly impaired. P53 null myoblasts show defective terminal differentiation and attenuated basal autophagy when switched into differentiating culture conditions. In conclusion, we demonstrate that basal autophagy contributes to a correct execution of myogenesis and that physiological p53 activity is required for muscle homeostasis by regulating metabolism and by affecting autophagy and differentiation.

8 March 2012 in Aging Cell
Verified
Journal Article
Open access
PDF file
Barbara PascucciBarbara Pascucci
Barbara Pascucci
TLTiziana Lemma
Tiziana Lemma
Egidio IorioEgidio Iorio
Egidio Iorio
SGSara Giovannini
Sara Giovannini
BVBruno Vaz
Bruno Vaz
MDMariarosaria D’eRrico
Mariarosaria D’eRrico
Summary: Cockayne syndrome (CS) is a rare hereditary multisystem disease characterized by neurological and development impairment, and premature aging. Cockayne syndrome cells are hypersensitive to oxidative stress, but the molecular mechanisms involved remain unresolved. Here we provide the first evidence that primary fibroblasts derived from patients with CS‐A and CS‐B present an altered redox balance with increased steady‐state levels of intracellular reactive oxygen species (ROS) and basal and induced DNA oxidative damage, loss of the mitochondrial membrane potential, and a significant decrease in the rate of basal oxidative phosphorylation. The Na/K‐ATPase, a relevant target of oxidative stress, is also affected with reduced transcription in CS fibroblasts and normal protein levels restored upon complementation with wild‐type genes. High‐resolution magnetic resonance spectroscopy revealed a significantly perturbed metabolic profile in CS‐A and CS‐B primary fibroblasts compared with normal cells in agreement with increased oxidative stress and alterations in cell bioenergetics. The affected processes include oxidative metabolism, glycolysis, choline phospholipid metabolism, and osmoregulation. The alterations in intracellular ROS content, oxidative DNA damage, and metabolic profile were partially rescued by the addition of an antioxidant in the culture medium suggesting that the continuous oxidative stress that characterizes CS cells plays a causative role in the underlying pathophysiology. The changes of oxidative and energy metabolism offer a clue for the clinical features of patients with CS and provide novel tools valuable for both diagnosis and therapy.